CREG1は,PINK1/パーキン媒介型ミトファギーの経路を通じたコンドロサイト熱滅亡を抑制することで,骨格関節炎の進行を緩和する
Xianming Fei1, Shuanggong Liu2, Guangxu Song2
1Department of Orthopaedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Biotechnology journal
|February 16, 2026
まとめ
E1A刺激遺伝子1 (CREG1) の細胞抑制剤は,コンドロサイト炎症を減少させることで,骨格関節炎 (OA) に対して保護します. CREG1はミトファジーとミトコンドリア機能を強化し,OAの潜在的な治療標的となる.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- 病理学 パトロジー
背景:
- 骨格関節炎 (OA) は退行性関節疾患で,NLRP3炎症体によって媒介されるコンドロサイト熱死が進行の主要な要因である.
- 細胞ホメオスタシスを調節するグリコプロテインであるE1A刺激遺伝子1 (CREG1) の細胞抑制剤は,OAの病原性において未定の役割を果たしている.
研究 の 目的:
- 骨格関節炎におけるCREG1の役割と分子メカニズムを調査する.
- CREG1がNLRP3の炎症体媒介性コンドロサイト炎症に影響を及ぼすかどうかを判断する.
主な方法:
- ヒトのOA軟骨の分析により,CREG1発現とコンドロサイト炎症を相関させる.
- LPS/ATP誘発のコンドロサイト炎症のインビトロモデルを使用して,CREG1がアポトーシス,細胞外マトリックス (ECM) 退化,NLRP3炎症体活性化,ミトファジー (PINK1/パーキン依存) に及ぼす影響を評価した.
- シクロスポリンA (CsA) を使ってミトファギーを抑制し,その影響を評価する.
主要な成果:
- CREG1発現はOA軟骨において有意に低下し,コンドロサイト発酵症と逆相関していた.
- CREG1を静止すると,アポトーシスが悪化し,ECMが劣化し,NLRP3炎症ゾームが活性化し,ミトファジーとミトコンドリア機能が低下します.
- CREG1の過剰発現は,ミトファギーを回復し,ミトコンドリアのホメオスタシスを改善し,NLRP3炎症体の活性化を抑制することで,これらの有害な効果を逆転させ,CsAによってブロックされた効果です.
結論:
- CREG1は,NLRP3炎症体誘発性コンドロサイト炎症を抑制することによって,OAの進行に対する保護因子として作用します.
- CREG1はPINK1/パーキン依存型ミトファギーの活性化によってこの保護を実現します.
- CREG1は,骨格関節炎の治療において有望な治療目標である.
関連する概念動画
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Regulated Protein Degradation
3.2K
3.2K
PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
The Intrinsic Apoptotic Pathway
8.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
TGF - β Signaling Pathway
10.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K

